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Abstract  27 
Objectives 28 
To assess the molecular epidemiology and prevalence of antibiotic resistance in E. coli 29 
causing urinary tract infections of elderly patients from community and hospital settings. Also 30 
to determine whether the possession of antibiotic resistance and virulence associated genes 31 
can be linked to patient location or clonal group of the organisms in question. 32 
Methods 33 
E. coli were isolated from the urine samples of elderly UTI from the Nottingham area and 34 
subjected to antibiotic susceptibility testing, virulence gene detection by PCR and MLST 35 
analysis. 36 
Results 37 
No correlation was observed between community or hospital derived strains with regards to 38 
antibiotic resistance levels or virulence gene profiles. E. coli ST131 was the predominant 39 
sequence type found in both hospital and community samples and demonstrated high levels 40 
of antibiotic resistance to the test panel but did not possess a significantly larger array of 41 
virulence genes, nor a specific gene profile compared to other sequence types. 42 
Conclusions 43 
The level of antibiotic resistance or virulence gene possession in uropathogenic E. coli is not 44 
directly associated with the health care setting of the patient, but there is a variation in 45 
antibiotic resistance and virulence gene possession depending on clonal group. ST131 is 46 
highly virulent and demonstrates high levels of antibiotic resistance but its virulence does not 47 
appear to be attributed to the possession of a specific virulence associated gene set, nor the 48 
possession of any VAG in significantly higher levels than any other sequence type.  49 
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Introduction 50 
Urinary tract infection is one of the most common nosocomial infections in the UK and also 51 
has a significant occurrence in the community.1,2 It is well known that E. coli is the primary 52 
etiologic agent of UTI in all age ranges, accounting for up to 80% of infections.3,4 Although 53 
once considered to be a clonal organism, it is now widely accepted that E. coli as a species is 54 
extremely heterogeneous and is subject to high rates of recombination within the accessory 55 
genome.5 Due to this high level of heterogeneity in the species, E. coli are broadly 56 
categorized into three main groups; (1) commensal E. coli, (2) intestinal E. coli such as ETEC, 57 
EPEC, EHEC and (3) Extra-intestinal Pathogenic E. coli or ExPEC. From this level of 58 
classification E. coli are usually further sub-divided into pathotypes on the basis of isolation 59 
site and the possession of certain “virulence factors”. For example within ExPEC, E. coli 60 
causing UTI are termed UPEC or uropathogenic E. coli on the basis that they were isolated 61 
from the bladder and possess at least two UPEC associated virulence factors.6 Although it is 62 
now appreciated that the level of heterogeneity within this species is immense, in a clinical 63 
setting UPEC are still traditionally classed and treated as a homogenous group of organisms. 64 
Due to the era of multilocus sequence typing we now know that E. coli strains within a 65 
population can vary greatly in terms of their evolutionary descent, which in turn can affect 66 
pathogenic potential and fitness in an infection. This is especially so in the case of the 67 
recently emerged ST131, which has been linked to community acquisition, and more 68 
significantly the world-wide dissemination of CTX-M-15.7-11  69 
 70 
It has been well reported that a reservoir of ESBL-producing organisms that usually cause 71 
urinary tract infections exists in long-term care facilities such as nursing homes.7,12 This will 72 
inevitably pose a greater risk to elderly patients living within long-term care facilities. Previous 73 
findings by our group reported that significant variations exist within a population of E. coli 74 
causing UTI in the Nottingham area and that a subgroup of organisms with increased 75 
virulence potential and antimicrobial resistance existed within this population.13 This 76 
investigation aimed to compare the molecular epidemiology, antimicrobial activity and 77 
virulence-associated gene (VAG) carriage of the aforementioned E. coli isolated from two 78 
populations within the same geographical area, namely the community and the hospital 79 
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setting and to determine if any observed differences could be attributed to clonal group or the 80 
possession of a specific virulence associated gene set. 81 
 82 
Methods 83 
 84 
Bacterial isolates 85 
Two hundred and fifty urine culture plates were collected at random from Nottingham 86 
University Hospitals (NUH) between October 2008 and June 2009. Cultures were collected 87 
anonymously (therefore no ethical approval or informed consent required) from both 88 
hospitalised and community patients aged 70 and over. The term ‘hospitalised patient’ is used 89 
to describe samples sent to the NUH clinical laboratory from inpatient departments and the 90 
term ‘community patient’ is used to describe patient samples from GP’s surgeries and out 91 
patient departments. All bacterial species were identified using API identification kits 92 
(Biomerieux). 93 
 94 
Multilocus Sequence Typing 95 
MLST was carried out on 121 E. coli isolates using the Achtman typing scheme 96 
(http://mlst.ucc.ie/mlst/dbs/Ecoli), adhering to the protocols published on the website. Briefly 97 
the seven house-keeping genes, adk, fumC, gyrB, icd, mdh, recA and purA, were amplified 98 
using a PCR protocol and the amplicons sequenced using the amplification primers. 99 
Individual gene sequences were searched against the database and assigned an allelic 100 
profile number. Sequence type (ST) designations were based upon the combination of 7 101 
alleles that each strain possessed. Bionumerics v.6.5 was used to generate a minimum 102 
spanning tree (MST) from non-concatenated sequences of the 7 alleles.  Therefore the MST 103 
illustrates clusters of closely related organisms and demonstrates the level of heterogeneity in 104 
terms of allele types present and not single nucleotide polymorphisms or phylogenetic 105 
relationship. 106 
 107 
Antibiotic susceptibility testing 108 
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Antibiotic susceptibility profiles were obtained for all isolates using breakpoint antibiotic media. 109 
The BSAC method for antimicrobial susceptibility testing was followed to prepare 110 
standardised inocula.14 The antibiotic panel used was as follows; Gentamicin (2µg/ml), 111 
Cefotaxime (1 µg/ml), Ceftazidime (1 µg/ml), Meropenem (2 µg/ml), Piperacillin-tazobactam 112 
(16 µg/ml), Co-amoxiclav (32 µg/ml), Trimethoprim (2 µg/ml), Ciprofloxacin (4 µg/ml), 113 
Cephradine (32 µg/ml), Nitrofurantoin (32 µg/ml), and Amoxicillin (32 µg/ml). All strains were 114 
tested for the ESBL production phenotype using ESBL combination ID discs (MAST). All 115 
isolates were also screened for the presence of the β-lactamase genes, blaTEM, blaSHV, blaCTX-116 
M and blaOXA using a previously described multiplex PCR.15 Reference strains E. coli NCTC 117 
13351, E. coli NCTC 13353 and Klebsiella pneumoniae NCTC 13368 were included as 118 
controls. For the typing of CTX-M genes PCR products were amplified using a previously 119 
published protocol,16 and amplicons were sequenced using the amplification primers. 120 
  121 
Detection of virulence associated genes 122 
The presence of 30 virulence associated genes (VAGs) was determined using previously 123 
published multiplex PCR protocols,17 which include genes involved in iron acquisition, 124 
adhesion, toxins and pathogenicity island markers among others. 125 
 126 
Cell cultures 127 
T24 human epithelial cells (HPA cultures) were grown in McCoy’s 5A modified media (Sigma, 128 
UK) supplemented with 10% fetal bovine serum (Sigma, UK) and 0.75% L-glutamine (Sigma, 129 
UK). Cells were grown in a 5% CO2 atmosphere at 37oC and sub-cultured twice-weekly. Two 130 
days prior to cell infection assays, the T24 cells were seeded into 24-well plates 131 
 132 
Association and invasion assays 133 
All strains were assayed for their ability to invade human bladder epithelial cells using a 134 
classical gentamicin protection assay as described previously.13 Assays were performed in 135 
triplicate wells in each assay and in duplicate on different days. Bacteria were cultured 136 
overnight in LB broth, harvested by centrifugation and re-suspended in supplemented tissue 137 
culture medium. Bacterial cell density was then adjusted to 2x107 cfu/ml, giving an MOI of 138 
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1:100. The invasive ExPEC reference strain, CFT073 was used as a positive control strain in 139 
all assays and E.coli DH5α was used as a negative control strain. The mean number of 140 
invasive bacteria was determined by Miles & Misra plate counts from triplicate wells. Strains 141 
that showed more than a 10-fold increase in invasion compared to CFT073 were classed as 142 
highly-invasive strains. Those that showed more than a 10-fold decrease in invasion 143 
compared to CFT073 were deemed to be strains of limited invasive potential.  144 
 145 
Statistical analysis 146 
Statistical analysis and production of heat maps was performed using SPSS PASW statistics 147 
software (version 18.0). χ 2 tests were performed to compare bacterial prevalence in different 148 
patient groups and the distribution of antimicrobial resistance and VAGs among strain types. 149 
 150 
Results  151 
UTI of the elderly is caused by an epidemiologically diverse population of E. coli 152 
Of the 250 urine culture plates collected from NUH, 158 originated from the community and 153 
92 were from hospitalised patients. E. coli was present in 60% of sample cultures compared 154 
to Enterococcus faecalis (45%), Proteus mirabilis (23%), Pseudomonas aeruginosa (20%), 155 
and Staphylococcus aureus (18%). There was a significant difference between the 156 
prevalence of E. coli in male (50/117) and female (100/133) cultures (P<0.001), but no 157 
significant difference in the prevalence of E. coli in samples from hospitalised patients (55%) 158 
or the community (63%). Sequence types (STs) were obtained for 121 E. coli isolates and 159 
uploaded to the E. coli MLST database (http://mlst.ucc.ie/mlst/dbs/Ecoli). A total of 52 STs 160 
were identified within the strain collection, including 11 novel STs. The most highly 161 
represented STs within the strain collection were the ST131 complex, which includes ST131, 162 
ST1461 and the novel ST1982, and accounted for 22% of the isolates. ST73 and ST69 163 
accounted for 11% and 9% of isolates respectively. A predominant ExPEC sequence type 164 
complex present in the MLST database, the ST95 complex was underrepresented in this 165 
strain set (3% of isolates). The ST131 complex showed a strong association with the 166 
community with 78% of isolates originating from patients within the community, compared 167 
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with 22% of samples from hospitalized patients (figure 1); this association however was not 168 
significantly different to observed distributions in other sequence types.  169 
 170 
E. coli from hospital and community environments do not exhibit significantly different 171 
levels of antibiotic resistance or VAG carriage but do show an association with CTX-M 172 
carriage 173 
The highest levels of resistance were observed against ampicillin (45% of strains), 174 
trimethoprim (41%), cephradine (26%) and ciprofloxacin (21%). Slight differences were 175 
observed between the resistance levels of hospital and community isolates although these 176 
differences were not statistically significant. With regards to β-lactamase gene carriage 6% of 177 
the E. coli isolates harboured blaSHV, 52% blaTEM (although it is not known which proportion of 178 
these fall into the extended spectrum category), 11% possessed blaCTX-M, and 7% blaOXA. 179 
Community strains possessed CTX-M significantly more frequently than their counterparts of 180 
hospital origin (P=0.008). The most frequently detected VAGs in the strain set (figure 2b) 181 
were the adhesin fimH (113/121), iron acquisition genes fyuA and iutA (98/121 and 64/121), 182 
the pathogenicity island marker PAI (85/121), the serum resistance gene traT (70/121), and 183 
the type II capsule marker kpsMTII (65/121). Possession of sub units of the pap operon, papA, 184 
papC and papG, which are associated with adhesion to the upper urinary tract, was markedly 185 
lower than fimH possession, which is involved in adhesion to the lower urinary tract (30-40% 186 
of isolates carried pap genes compared to 94% fimH).  This difference was observed across 187 
the strain set and no significant difference was observed in the prevalence of any gene 188 
between community and hospital derived strains. 189 
 190 
There is evidence of a correlation between clonal group and antibiotic resistance 191 
The distribution of resistance to trimethoprim, ciprofloxacin, ampicillin and cephradine was not 192 
evenly distributed across different clonal groups (Kruskal Wallis test for independent samples, 193 
P<0.05). More specifically the largest percentage of resistant strains (classed as strains with 194 
the widest range of resistances to the 11 antibiotics on the panel) belonged to ST131 (Figure 195 
3a). Within the ST131 complex 74% of isolates were classed as resistant to trimethoprim and 196 
ciprofloxacin and 70% were resistant to ampicillin. Thirty-seven percent of isolates within the 197 
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ST131 complex were resistant to over five antibiotics on the panel. When compared to non-198 
ST131 isolates, the ST131 complex strains are significantly more resistant to cefotaxime 199 
(P=0.012), ampicillin (P=0.004), trimethoprim (P<0.001) and ciprofloxacin (P<0.001). 200 
Interestingly the ST131 complex also had a high carriage rate of β-lactamase genes, 201 
accounting for 25% of blaTEM+ strains, 46% of blaCTX-M+ strains and 63% of blaOXA+ strains. 202 
When compared to non-ST131 strains, the ST131 complex possesses significantly more 203 
blaCTX-M (P=0.009) and blaOXA (P=0.014). Overall 26% of ST131 strains possessed blaCTX-M, 204 
which was the highest prevalence of any of the sequence types from this study. For this 205 
reason all blaCTX-M genes present in ST131 strains were typed and were all subsequently 206 
confirmed to be CTX-M-15. Interestingly the only strains that demonstrated phenotypic ESBL 207 
activity were the E. coli ST131 that possessed CTX-M-15. Other blaCTX-M+ strains from 208 
different clonal groups demonstrated no phenotypic extended spectrum resistance.  209 
 210 
There is no correlation between invasive potential and virulence gene carriage 211 
Although some genes such as fimH, iutA, fyuA, kpsMTII II, traT and the pathogenicity island 212 
were highly prevalent across all sequence types, the amount of VAGs possessed varied by 213 
sequence type. ST’s 12, 1262 and 127, which exhibit low levels of antibiotic resistance, 214 
possess the highest levels of VAGs (11, 10 and 9 VAGs on average respectively). The highly 215 
antibiotic resistant ST131 in comparison possessed on average only 6 VAGs, and these were 216 
all VAGs common to the other sequence types. The ST131 complex does not appear to 217 
possess a specific gene set to which its highly virulent nature can be attributed. To determine 218 
whether the presence of a specific set of virulence factors had an impact on the invasive and 219 
therefore pathogenic nature of the bacterium the invasive potential of the strains was 220 
determined using gentamicin protection assays. Bacterial strains were designated as highly 221 
invasive if they demonstrated levels of invasion over 10-fold higher than that of the reference 222 
strain, CFT073, which exhibited variation of less than 1 log across all assays performed (less 223 
than 10 fold). Strains that demonstrated invasion levels 10-fold lower than CFT073 were 224 
deemed those of limited invasive potential. In total 24 strains (20%) exhibited a low invasive 225 
phenotype, 48 (40%) invaded within a 1-log range of CFT073 and 49 (40%) were designated 226 
as highly invasive. A highly invasive phenotype could not be attributed to a specific set of 227 
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VAGs. However, sfa/focDE, papC and papG allele III were significantly more prevalent in 228 
strains with limited invasive potential than those with a highly invasive phenotype (P<0.001, 229 
P=0.004 and P=0.01 respectively, Χ2 with 95% confidence).  230 
Within the ST131 complex 56% of strains exhibited a highly invasive phenotype, 30% 231 
demonstrated an invasive capability within a 1-log range of that of CFT073 and 14% 232 
demonstrated limited invasive potential. When compared to the rest of the population, strains 233 
within the ST131 complex did not invade to significantly higher numbers (Student’s t-test, 234 
95% confidence P=0.122).  235 
 236 
Discussion 237 
This investigation set out to characterise a population of E. coli causing UTI in hospitalised 238 
and community elderly patients within the Nottingham area. It was found that the population 239 
was extremely diverse epidemiologically and consisted of 52 different sequence types. The 240 
most frequently encountered clonal group was the ST131 complex which has links to the 241 
community and ESBL production. It has been well reported that a reservoir of ESBL-242 
producing organisms, which usually cause urinary tract infections, exists in the community in 243 
long-term care facilities.7,12,18 Whereas no significant difference was observed in the 244 
antimicrobial resistance patterns of the two groups, there was an association with CTX-M 245 
gene carriage and the community location. This can be linked to the high representation of 246 
ST131 within the dataset as E. coli ST131 is known to be responsible for the world-wide 247 
dissemination of CTX-M-15.10,11,19 Within the ST131 complex significantly higher levels of 248 
resistance to the front line antibiotics ciprofloxacin, trimethoprim, ampicillin and cefotaxime 249 
was observed when compared to non-ST131 strains. The ST131 complex also had a 250 
significant association with CTX-M and OXA gene carriage, thus explaining the significant 251 
association with CTX-M and the community. It is not surprising that all blaCTX-M genes detected 252 
in ST131 were CTX-M-15, but it is somewhat surprising however that a higher rate of carriage 253 
was not observed.7,20 It is reported that CTX-M-15 is only associated with certain ST131 254 
clusters, differentiated by pulse type,21 and this is the focus of further investigation to 255 
determine if a specific cluster is over-represented in this population.  256 
 257 
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With regards to virulence associated gene possession it was found that fimH, iutA, fyuA, 258 
kpsMTII, traT and PAI were present in high levels across the whole population, and no 259 
individual VAG profiles could be perceived for any of the sequence types. The sequence 260 
types that possessed the most VAGs on average were those that possess low levels of 261 
antibiotic resistance, ST12, ST127 and ST1262. It has been suggested that ST131 goes 262 
against the age old ethos that a pathogen can be either antibiotic resistant or possess high 263 
levels of virulence due to the enormous cost of maintaining both traits,22,23 with previous 264 
studies linking ST131 with increased level of VAG carriage compared to ExPEC of other ST 265 
complexes.24 In this study however the ST131 complex, which is highly antibiotic resistant, 266 
does not seem to possess any specific set of VAGs nor does it possess those VAGs common 267 
to other UPECs in significantly higher levels than the other sequence types. This would 268 
suggest that the key to ST131’s elevated virulence potential cannot be generalised to a 269 
specific VAG set or increased carriage of VAGs in general. The general hypothesis that 270 
ST131 strains exhibit increased virulence which cannot be attributed to a specific gene set 271 
was tested by comparing the VAG profiles of a group of strains with high, normal and limited 272 
invasive potential. Strains within the ST131 complex did not exhibit an invasive potential at 273 
significantly higher levels than other ExPEC strains from different ST complexes. This not 274 
only suggests that the high levels of virulence reported in ST131 are not a result of invasive 275 
potential but also cannot be attributed to the possession of any unique VAGs or the 276 
possession of any VAGs to any greater extent than that of other ExPEC strains. It is clear that 277 
an in depth study of the specific genomic content of the ST131 population is required, and is 278 
the focus of ongoing work in our laboratory. 279 
 280 
This investigation found that vast levels of heterogeneity can be observed within a single 281 
population of E. coli causing UTI of the elderly. Any association between patient location and 282 
antibiotic resistance was attributed to the prominent presence of the ST131 complex within 283 
the dataset, which exhibited significantly higher levels of antibiotic resistance and ESBL gene 284 
carriage than any other sequence type. No individual virulence associated gene profiles 285 
specific to sequence types were observed and the ST131 complex does not possess any 286 
VAG at higher levels than other sequence types, nor could VAG possession or invasive 287 
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potential be seen to be responsible for the reported high levels of virulence in the ST131 288 
complex. In short E. coli ST131 continues to emerge as an increasing threat to human health 289 
due to its increasing prevalence and high rates of antimicrobial resistance, but there is no 290 
clear pattern of virulence associated gene carriage which marks the ability of this ST to 291 
predominate and exhibit increased virulence. 292 
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Fig. 1. Minimum spanning tree of E. coli sequence types from elderly urinary tract infections. 373 
Grey shading indicates proportion of isolates within ST derived from hospital environments 374 
and un-shaded areas indicate proportion of isolates within ST derived from community 375 
environments. Strains within the same ST possess 7 identical alleles, whereas a single locus 376 
variant possesses one different allele to the other ST and a double locus variant differs by two 377 
alleles. 378 
 379 
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Fig. 2. (a) Antibiotic resistance prevalence in urinary E. coli isolates of hospital and 381 
community origin. Black bars, hospital isolates; white bars, community isolates. (b) Virulence 382 
associated gene prevalence in urinary E. coli isolates of hospital and community origin. Black 383 
bars, hospital isolates; white bars, community isolates.  384 
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 385 
Fig. 3. (a) Heat map of antimicrobial resistance distribution across predominant E. coli 386 
sequence types. Darker shaded areas indicate higher prevalence. Abbreviations; blaTEM, TEM 387 
β-lactamase gene; blaSHV, SHV β-lactamase gene; blaCTX-M, CTX-M β-lactamase gene; blaOXA, 388 
OXA β-lactamase gene; GM, Gentamicin; CTX, Cefotaxime; CAZ, Ceftazidime; MER, 389 
Meropenem; PIP-TAZ, Piperacillin-tazobactam; AUG, Augmentin; TRM, Trimethoprim; CIP, 390 
Ciprofloxacin; CEP, Cephradine; NT, Nitrofurantoin; AMP, Ampicillin. (b) Heat map of 391 
virulence associated gene distribution across predominant E. coli sequence types.  392 
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Fig. 4. Virulence associated gene prevalence in E. coli isolates with different invasive 394 
potentials. White bars, isolates with low invasive potential; hatched bars, strains with normal 395 
invasive potential comparable to that of CFT073; black bars, strains with high invasive 396 
potential. 397 
 398 
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